Compounded medications are prepared by state-regulated pharmacies that follow strict safety protocols but are not FDA-approved, meaning they havent undergone the same rigorous testing for efficacy and safety as brand-name medications
The simultaneous targeting of GIP and GLP-1 receptors delivers superior clinical outcomes compared to single-agonist alternatives, while robust regulatory approval provides market confidence and development pathway clarity
GLP-1 receptor agonists, like Ozempic, Wegovy, Mounjaro, and Zepbound, initially developed for diabetes management, show promising potential in treating psoriasis and psoriatic arthritis (PsA)
Each spectrum was integrated between 0.41.5 and 1.55.0 Hz 28 to calculate the power in the low frequency (LF) and high frequency (HF) bands, respectively
Xie Y, Liu X, Xie D, Zhang W, Zhao H, Guan H, et al